Behandlung von verrucae vulgares mit dithranol-salizylsäure-haltiger salbe - Anwendungsbeobachtung bei 30 patienten

Translated title of the contribution: Treatment of common warts with dithranol salicylic acid-containing ointment - Non-interventional trial

Vesna Mirceva, B. Jeßberger, A. Konstantinow, N. A. Papadopulos, R. Hein, J. Ring, K. Brockow

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Background: The treatment of vulgar warts is difficult. The efficiency of a dithranol (anthralin) salicylic acid-containing wart ointment listed in the German "Neue Rezeptur Formularium" (NRF) has not yet been prospectively examined. Patients and Methods: In an observational study, 30 patients with vulgar warts on hands and/or feet were treated with a dithranol salicylic acid-containing ointment (NRF 11.31) for up to 12 weeks over a period of 12 months. Efficiency and side effects of the treatment were prospectively recorded and evaluated. Results: In the 30 patients, 21 warts were localized on plantae, 2 on toes, 8 on fingers as well as 6 on palmae. After 8 weeks of therapy, 65% of the warts had completely healed, another 30% showed regression. This corresponds to a response rate of 95%. The wart localization had no significant influence on the efficiency of treatment. The mean therapy period until healing was 6.2 weeks. Conclusion: The combination of dithranol and salicylic acid is an effective therapy of vulgar and plantar warts with little side effects.

Translated title of the contributionTreatment of common warts with dithranol salicylic acid-containing ointment - Non-interventional trial
Original languageGerman
Pages (from-to)428-432
Number of pages5
JournalAktuelle Dermatologie
Volume34
Issue number11
DOIs
StatePublished - Nov 2008
Externally publishedYes

Fingerprint

Dive into the research topics of 'Treatment of common warts with dithranol salicylic acid-containing ointment - Non-interventional trial'. Together they form a unique fingerprint.

Cite this